VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
EDIT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
EDITEditas Medicine, Inc.
$2.57$394M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksEDITQuarterly Financials

Editas Medicine, Inc. (EDIT) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Editas Medicine, Inc. (EDIT) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

EDIT Income Statement

Quarterly statement

EDIT Income Statement

Editas Medicine, Inc. (EDIT) annual income statement — 13-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Sales/Revenue11.89M2.83M24.74M7.54M3.58M4.66M30.6M61K513K1.14M60.05M5.34M2.89M9.85M6.54M42K6.36M6.77M12.47M6.2M
Revenue Growth %232.31%-39.22%-19.16%12265.57%597.47%310.4%-49.04%-98.86%-82.23%-88.48%818.74%12604.76%-54.62%45.49%-47.58%-99.32%1578.63%4.19%9.2%-90.14%
Cost of Goods Sold0483K019.77M16.18M26.59M48.61M1.6M1.42M1.41M1.47M1.51M29.78M37.8M52M41.33M43.66M37.98M37.55M29.27M
COGS % of Revenue-17.06%-262.16%452.24%570.91%158.84%2621.31%276.8%124.14%2.44%28.37%1031.49%383.76%795.56%98395.24%686.25%560.86%301.17%472.24%
Gross Profit11.89M2.35M24.74M-12.23M-12.6M-21.93M-18.01M-1.54M-907K-274K58.58M3.82M-26.89M-27.95M-45.46M-41.28M-37.3M-31.2M-25.08M-23.07M
Gross Margin %100%82.94%100%-162.16%-352.24%-470.91%-58.84%-2521.31%-176.8%-24.14%97.56%71.63%-931.49%-283.76%-695.56%-98295.24%-586.25%-460.86%-201.17%-372.24%
Gross Profit Growth %194.34%110.7%237.4%-695.32%-1289.53%-7905.47%-130.74%-140.24%96.63%99.02%228.86%109.26%27.9%10.42%-81.24%-78.97%-11.75%11.94%49.92%-179.75%
Operating Expenses30.44M27.35M38.76M12.32M38.94M54.23M28.59M64.13M71M66.72M82.55M53.98M17.2M23.01M17.98M16.24M16.94M19.55M16.53M16.18M
OpEx % of Revenue256.05%966.13%156.65%163.28%1088.35%1164.19%93.41%105127.87%13839.38%5878.15%137.46%1011.71%595.84%233.56%275.15%38657.14%266.22%288.66%132.54%261.17%
Selling, General & Admin11.6M10.23M11.35M12.32M12.86M13.38M16.35M18.09M18.21M19.34M14.46M14.99M17.2M23.01M17.98M16.24M16.94M19.55M16.53M16.18M
SG&A % of Revenue97.59%361.5%45.89%163.28%359.39%287.14%53.44%29652.46%3548.93%1703.88%24.07%280.87%595.84%233.56%275.15%38657.14%266.22%288.66%132.54%261.17%
Research & Development20.18M2.83M27.4M19.77M16.18M26.59M48.61M47.64M52.79M47.38M68.09M5.34M29.78M37.8M52M41.33M43.66M37.98M37.55M29.27M
R&D % of Revenue169.72%100%110.76%262.16%452.24%570.91%158.84%78096.72%10290.45%4174.27%113.39%100%1031.49%383.76%795.56%98395.24%686.25%560.86%301.17%472.24%
Other Operating Expenses-1000K1000K0-1000K1000K1000K-1000K-1000K0001000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K
Operating Income-18.55M-25M-14.02M-24.55M-51.54M-76.16M-46.59M-65.67M-71.9M-66.99M-23.96M-50.16M-44.09M-50.96M-63.45M-57.52M-54.23M-50.75M-41.61M-39.25M
Operating Margin %-156.05%-883.19%-56.65%-325.44%-1440.58%-1635.1%-152.24%-107649.18%-14016.18%-5902.29%-39.9%-940.09%-1527.33%-517.32%-970.72%-136952.38%-852.47%-749.52%-333.71%-633.42%
Operating Income Growth %64%67.17%69.92%62.62%28.31%-13.69%-94.45%-30.91%-63.07%-31.46%62.23%12.79%18.7%-0.42%-52.48%-46.54%2.11%10.78%36.83%-536.68%
EBITDA-18.14M-24.52M-13.21M-23.83M-49.71M-74.25M-45.21M-64.07M-70.48M-65.58M-22.5M-48.65M-42.55M-49.42M-61.87M-55.92M-52.64M-49.19M-40.1M-38.06M
EBITDA Margin %-152.55%-866.13%-53.4%-315.88%-1389.32%-1593.95%-147.73%-105027.87%-13739.38%-5778.15%-37.46%-911.71%-1473.99%-501.64%-946.59%-133133.33%-827.35%-726.51%-321.59%-614.22%
EBITDA Growth %63.51%66.97%70.78%62.81%29.47%-13.21%-100.98%-31.69%-65.63%-32.71%63.64%13%19.15%-0.46%-54.29%-46.9%2.91%11.72%38.01%-477.01%
D&A (Non-Cash Add-back)416K483K805K721K1.83M1.92M1.38M1.6M1.42M1.41M1.47M1.51M1.54M1.54M1.58M1.6M1.6M1.56M1.51M1.19M
EBIT-19.94M-23.91M-6.08M-22.72M-51.22M-73.87M-34.36M-62.14M-67.61M-61.95M-23.96M-50.16M-44.09M-50.96M-63.45M-57.52M-54.23M-50.75M-41.61M-39.25M
Net Interest Income-1.06M134K1K-568K67K500K1.2M3.53M4.3M5.04M5.1M5.14M3.81M3.51M1.42M1.79M546K469K1.91M152K
Interest Income01.21M-6.63M1.83M2.09M2.72M1.2M3.53M4.3M5.04M5.1M5.14M3.81M3.51M1.42M1.79M546K469K1.91M152K
Interest Expense1.06M1.07M-6.63M2.4M2.02M2.22M00000000000000
Other Income/Expense324K21K8.4M-569K-1.69M75K1.2M3.52M4.3M5.04M5.09M5.14M3.8M1.93M2.71M1.79M781K235K174K171K
Pretax Income-18.23M-24.98M-5.62M-25.12M-53.23M-76.09M-45.4M-62.14M-67.61M-61.95M-18.87M-45.02M-40.29M-49.04M-60.74M-55.73M-53.45M-50.52M-41.44M-39.08M
Pretax Margin %-153.32%-882.44%-22.72%-332.98%-1487.84%-1633.49%-148.33%-101870.49%-13178.75%-5458.15%-31.43%-843.68%-1395.57%-497.78%-929.28%-132680.95%-840.19%-746.05%-332.31%-630.66%
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-18.23M-24.98M-5.62M-25.12M-53.23M-76.09M-45.4M-62.14M-67.61M-61.95M-18.87M-45.02M-40.29M-49.04M-60.74M-55.73M-53.45M-50.52M-41.44M-39.08M
Net Margin %-153.32%-882.44%-22.72%-332.98%-1487.84%-1633.49%-148.33%-101870.49%-13178.75%-5458.15%-31.43%-843.68%-1395.57%-497.78%-929.28%-132680.95%-840.19%-746.05%-332.31%-630.66%
Net Income Growth %65.76%67.17%87.62%59.58%21.26%-22.82%-140.52%-38.03%-67.8%-26.34%68.93%19.21%24.63%2.93%-46.58%-42.59%3.26%10.95%33.7%-599.83%
Net Income (Continuing)-18.23M-24.98M-5.62M-25.12M-53.23M-76.09M-45.4M-62.14M-67.61M-61.95M-18.87M-45.02M-40.29M-49.04M-60.74M-55.73M-53.45M-50.52M-41.44M-39.08M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.15-0.26-0.06-0.28-0.63-0.92-0.55-0.75-0.82-0.76-0.23-0.55-0.56-0.66-0.80-0.78-0.77-0.73-0.61-0.57
EPS Growth %76.19%71.74%89.49%62.67%23.17%-21.05%-139.13%-36.36%-46.43%-15.15%71.25%29.49%27.27%9.59%-31.15%-36.84%4.94%15.12%39%-575%
EPS (Basic)-0.15-0.26-0.06-0.28-0.63-0.92-0.55-0.75-0.82-0.76-0.23-0.55-0.56-0.66-0.80-0.78-0.77-0.74-0.61-0.57
Diluted Shares Outstanding119.29M97.88M88.75M90.09M84.41M83.06M82.61M82.49M82.31M81.94M81.71M81.65M71.38M68.92M68.79M68.74M68.64M68.48M68.36M68.22M
Basic Shares Outstanding119.29M97.88M88.75M90.09M84.41M83.06M82.61M82.49M82.31M81.94M81.71M81.65M71.38M68.92M68.79M68.74M68.64M68.26M68.36M68.22M
Dividend Payout Ratio--------------------